Carlsmed, Inc. (CARL) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Carlsmed, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.091 -- 00:00:03.053 Ladies and gentlemen, thank you for standing by. 00:00:03.053 -- 00:00:07.696 And welcome to the Carlsmed Second Quarter 2026 Earnings Conference Call. 00:00:07.696 -- 00:00:11.218 At this time, all participants are in a listen-only mode. 00:00:11.218 -- 00:00:14.660 After the speaker's presentation, there will be a question and answer session. 00:00:14.660 -- 00:00:20.243 I would now like to turn the conference over to your first speaker today, Stephanie Zhadkevich, 00:00:20.243 -- 00:00:21.524 Investor Relations. 00:00:21.524 -- 00:00:24.185 Please go ahead, Stephanie. 00:00:31.351 -- 00:00:32.791 Thank you, operator. 00:00:32.791 -- 00:00:37.292 Welcome to Carlsmed's second quarter 2026 earnings call. 00:00:37.292 -- 00:00:42.394 Joining me today are Mike Cordonnier, Chairman and Chief Executive Officer, 00:00:42.394 -- 00:00:45.874 and Leo Greenstein, Chief Financial Officer. 00:00:45.874 -- 00:00:50.075 Before we begin, I would like to caution that comments made during this call will include 00:00:50.075 -- 00:00:53.816 forward-looking statements within the meaning of the Private Securities Litigation Reform 00:00:53.816 -- 00:00:58.957 Act of 1995. All statements made on this call that do not relate to matters of historical 00:00:58.957 -- 00:01:01.972 fact should be considered forward-looking statements. 00:01:01.972 -- 00:01:07.335 including statements regarding the market in which Carlsmed operates, trends, expectations, 00:01:07.335 -- 00:01:13.358 and demand for Carlsmed's products, expectations with respect to reimbursement, 00:01:13.358 -- 00:01:18.461 statements about the company's clinical data, surgeon adoption and utilization, and 00:01:18.461 -- 00:01:24.184 Carlsmed's expected financial performance, growth prospe...